Goldman Sachs Group Inc Moderna, Inc. Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,185,558 shares of MRNA stock, worth $275 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,185,558

Previous 3,929,912 6.51%

Holding current value

$275 Million

Previous $419 Million 18.69%

% of portfolio

0.09%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $25.9 Million - $42.6 Million	255,646 Added 6.51%	4,185,558 $497 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $53.1 Million - $71.8 Million	-621,714 Reduced 13.66%	3,929,912 $419 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $31.1 Million - $46.7 Million	447,639 Added 10.91%	4,551,626 $453 Million
Q3 2023 May 14, 2024	SELL	$96.41 - $126.61 $43.2 Million - $56.7 Million	-447,639 Reduced 9.83%	4,103,987 $424 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $61 Million - $80.1 Million	632,350 Added 18.21%	4,103,987 $424 Million
Q2 2023 May 14, 2024	BUY	$118.5 - $160.53 $48.9 Million - $66.2 Million	412,412 Added 13.48%	3,471,637 $422 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $48.9 Million - $66.2 Million	412,412 Added 13.48%	3,471,637 $422 Million
Q1 2023 May 14, 2024	BUY	$135.66 - $197.02 $41.5 Million - $60.3 Million	306,053 Added 11.12%	3,059,225 $470 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $41.5 Million - $60.3 Million	306,053 Added 11.12%	3,059,225 $470 Million
Q4 2022 May 14, 2024	BUY	$118.38 - $210.04 $176 Million - $313 Million	1,490,684 Added 118.08%	2,753,172 $495 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $176 Million - $313 Million	1,490,684 Added 118.08%	2,753,172 $495 Million
Q3 2022 May 14, 2024	SELL	$118.07 - $194.18 $178 Million - $293 Million	-1,506,938 Reduced 54.41%	1,262,488 $149 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $178 Million - $293 Million	-1,506,938 Reduced 54.41%	1,262,488 $149 Million
Q2 2022 May 14, 2024	SELL	$117.13 - $176.59 $209 Million - $315 Million	-1,782,200 Reduced 39.16%	2,769,426 $396 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $136 Million - $204 Million	1,156,961 Added 71.75%	2,769,426 $396 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $39.7 Million - $73.8 Million	313,877 Added 24.17%	1,612,465 $278 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $64.6 Million - $105 Million	-286,235 Reduced 18.06%	1,298,588 $330 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $352 Million - $768 Million	1,584,823 New	1,584,823 $610 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Moderna, Inc. Transaction History